www.bna.com White Collar Crime Report
HomeIndexTable of CasesFeedbackwww.bna.com

Printable version (PDF) 

INDEX
Vol. 5, Nos. 1 - 27, pp. 1 - 954
Jan. 1 -- Dec. 31, 2010

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

    DEFENSE CONTRACTS
      – Bribery
        – – Construction firm executive pleads guilty to paying Army contracting officer (D. Colo.), 928
        – – Retired Army major, sentencing (M.D. Ga.), 15
      – FCPA, UK-based firm, bribes to public officials, guilty plea (D.D.C.), 178; possible export license sanctions, 304
      – Fraud charges time-barred (S.D. Cal.), 501
    DEPARTMENT OF
      See specific department e.g., JUSTICE DEPARTMENT (DOJ)
    DISCOVERY
      – Attorney-client privilege
      – Collaborative cross-agency investigations, DOJ guidance, 193
      – DOJ memo re guidelines and local policies, 31
      – Electronic discovery in FCPA investigations, BNA Insights, 909
      – Grand jury subpoena for documents obtained in civil lawsuit (9th Cir.), 936
      – SEC deposition testimony, nondisclosure to fraud defendants did not undermine convictions (E.D.N.Y.), 526
      – Text messages sent between FBI agents and cooperating witness deleted (D.N.J.), 839
    DOCTORS
    DOJ
    DOUBLE JEOPARDY
      – Bankruptcy fraud and obstruction of justice convictions (7th Cir.), 141
      – Conspiracy, separate punishment for violations of offense and fraud portions of federal statute (3d Cir.), 356
      – Enron exec reindictment challenge, jurisdiction (5th Cir.), 328; (U.S., rev den), 767
      – Federal conspiracy statute, separate punishments for violating “offense” and “fraud” portions, rehearing (3d Cir.), 78
      – Health care benefits program, embezzlement and mail fraud charges (2d Cir.), 733
      – Mail fraud, acquittal as bar to retrial on hung counts (D.C. Cir.), 536
    DRUGS
      – Accounting fraud
        – – Bristol-Myers Squibb executives, deferred prosecution agreement (D.N.J.), 497
        – – Duane Reade drug store executives convicted (S.D.N.Y.), 428
      – Adulterated drugs, GlaxoSmithKline to pay penalties (D. Mass.), 756
      – AIDS
      – Average wholesale price inflation, makers settle charges, 896
      – Controlled substances, doctor and wife/nurse convicted of illegal distribution (D. Kan.), 499; sentencing, 759
      – Counterfeit drug trafficking
        – – Cancer drugs, sentencing (D. Ariz.), 602
        – – Evidence that mark was on principal register not introduced (5th Cir.), 185
      – Dentist drug trafficking, sentencing (Ky. Cir. Ct.), 38
      – Doctor pleads guilty to illegal distribution of prescription drugs (W.D. Mo.), 529; sentencing, 807
      – Fake prescriptions written by doctor, indictment (D. Colo.), 651
      – False Claims Act and anti-kickback enforcement, BNA webinar, 579
      – FCPA prosecutions, international cooperation trend, lawyers discuss, 157
      – FDA increased enforcement efforts, conferees discuss, 771
      – Food, Drug and Cosmetic Act violations
        – – Individual liability, prosecutors focus on, BNA Insights, 862
        – – Misdemeanor prosecutions of high-level executives, BNA Insights, 544
      – Illegal internet prescription sales, physician sentencing (D.N.J.), 290
      – Insider trading on adverse clinical trial data, doctor charged (S.D.N.Y.), 752
      – Kadian false claims and kickback payments, settlement, 224
      – Kickbacks to doctors for writing prescriptions, Abbott subsidiary to pay fines (M.D. La.), 885
      – Marketing for off-label use
        – – Botox, Allergan settles charges (N.D. Ga.), 652
        – – GlaxoSmithKline officer indicted for obstruction and false statements (D. Md.), 795; not guilty plea, 884; Special Report, 946
        – – Increased prosecution of executives, legal group urges FDA to abandon, 773
        – – Neurontin, Pfizer jury verdict (D. Mass.), 261
        – – Sentencing in Actimmune case, proof of loss (N.D. Cal.), 812
        – – Topamax, plea agreement (D. Mass.), 319
        – – Trileptal, Novartis criminal and civil settlement, 77
        – – Zonegran epilepsy drug, Elan to pay fine (D. Mass.), 886
      – Medicaid billing fraud
        – – Clinical testing laboratory indicted for drug screening kickback scheme (Mass. Super. Ct.), 494
        – – Forged prescriptions scheme, sentencing (N.D. Ga.), 14
        – – Pharmacist indicted (N.Y. Sup. Ct.), 799
      – Medicare billing fraud
        – – Injectable cancer drugs not provided to patients, doctor plea agreement (C.D. Cal.), 320
        – – Pharmacy scheme, sentencing (S.D. Fla.), 599
      – Misbranded drugs sold for nonexistent Lyme disease epidemic, guilty plea (D. Kan.), 698; doctor pleads guilty, 758
      – Nurse's theft of patient pain drugs, abuse-of-trust sentence enhancement (1st Cir.), 39
      – Pain drugs, fabricating data for research journals, doctor's plea offer (D. Mass.), 70; sentencing, 503
      – Search of computer records of major league baseball players' test results, amended opinion issued (9th Cir., en banc), 649
      – Unapproved and misbranded drug distribution, maker pleads guilty (D. Mass.), 653
      – Web pharmacy law, Controlled Substances Act, vagueness (8th Cir.), 328
    DUE PROCESS
      – Armed services, guilty pleas, appeals, closely related offense doctrine (C.A.A.F.), 361
      – Supervised release, revocation of (8th Cir.), 606

Contact the Webmaster at webmaster@bna.com
1801 S. Bell Street, Arlington, VA 22202 - Phone: 1-800-372-1033

Copyright © The Bureau of National Affairs, Inc. All Rights Reserved.